openPR Logo
Press release

Pulmonary Edema Market 2018 | Size, Share and Growth Analysis by Industry Professionals by 2023 | MarketResearchFuture.com

11-19-2018 10:24 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Pulmonary Edema Market

Pulmonary Edema Market

Market Highlights for Global Pulmonary Edema Market

Increasing prevalence of pulmonary edema and diseases like kidney failure, heart diseases, and others along with the growing geriatric population boosts the market growth. On the other hand, low per capita healthcare expenditure in the middle and low-income countries, and lack of awareness about the disease are estimated to restrain the market growth.

The global pulmonary edema market is expected to grow at an approximate CAGR of 7.2% during the forecast period.

Key Players for Global Pulmonary Edema Market

Pfizer Inc. (U.S.), ARGON MEDICAL (U.S.), Edwards Lifesciences Corporation (U.S.), BD (U.S.), Alcaliber S.A. (Spain), Lupin Pharmaceuticals, Inc. (India), Vitaltec Corporation (China), Medtronic (U.S.), Koninklijke Philips N.V. (The Netherlands), Siemens Healthcare GmbH (Germany), Hitachi Medical Corporation (U.S.), and Canon Medical Systems Corporation (Japan).

Get PDF Sample Copy at https://www.marketresearchfuture.com/sample_request/5607

Segmentation for Global Pulmonary Edema Market

The global pulmonary edema market is segmented on the basis of type, diagnosis, treatment, and end user.On the basis of the type, the market is segmented into cardiogenic edema, cardiogenic edema, and others. On the basis of the diagnosis, the market is categorized into blood tests, imaging, and others. The blood tests segment is sub-segmented into b-type natriuretic peptide (BNP), blood count test, kidney function test, and others. The imaging segment is sub-segmented into chest x-ray, electrocardiogram, echocardiogram, transesophageal echocardiography, pulse oximetry, and others. On the basis of the treatment, the market is segmented into preload reducers, morphine, suction catheter, and others. The preload reducers segment is sub-segmented into nitroglycerin, diuretics, and others. On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.

Regional Analysis for Global Pulmonary Edema Market

America dominates the Global Pulmonary Edema Market owing to a well-developed healthcare sector and high per capita healthcare expenditure. Moreover, the presence of developed economies like U.S. and Canada and Global players such as Pfizer Inc., Edwards Lifesciences Corporation, ARGON MEDICAL, and others within the regional boundaries of the Americas fuels the market growth.

Europe is the second largest Pulmonary Edema Market and is followed by the Asia Pacific due to the availability of funds for research, the presence of developed economies like France, Italy, and Germany within the region.

The Asia Pacific is the fastest growing region in the market due to the presence of developing economies like India and China within the region. Moreover, rising healthcare expenditure and favorable government policies drive the market growth.

The Middle East & Africa holds the least share of the Global Pulmonary Edema Market. Presence of poor economies, especially within in the African region makes the market to lag. Middle East accounts for the majority of the market share in the Middle East & Africa region due to a huge healthcare expenditure by the presence of the developed economies such as Saudi Arabia, Kuwait, and Qatar within the region.

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition 

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

TOC Continued…

Browse Complete 90 Pages Premium Research Report Enabled with 92 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/pulmonary-edema-market-5607

LIST OF TABLES

Table 1 Pulmonary Edema Industry Synopsis, 2017 – 2023

Table 2 Global Pulmonary Edema Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Global Pulmonary Edema Market By Region, 2017 – 2023, (USD Million)

Table 4 Global Pulmonary Edema Market By Types, 2017 – 2023, (USD Million)

Table 5 Global Pulmonary Edema Market By Diagnosis, 2017 – 2023, (USD Million)

Continued..

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Pulmonary Edema Market

Figure 3 Market Dynamics For Global Pulmonary Edema Market

Figure 4 Global Pulmonary Edema Market Share, By Type 2016

Figure 5 Global Pulmonary Edema Market Share, By Diagnosis 2016

Continued………

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Edema Market 2018 | Size, Share and Growth Analysis by Industry Professionals by 2023 | MarketResearchFuture.com here

News-ID: 1380749 • Views:

More Releases from Market Research Future

Rugged Tablet Market Size to Reach USD 2,580.38 Million by 2035 Fueled by Industrial and Field Applications
Rugged Tablet Market Size to Reach USD 2,580.38 Million by 2035 Fueled by Indust …
The Rugged Tablet Market report provides comprehensive insights into market trends, competitive landscape, growth drivers, and emerging opportunities across global regions. Rugged Tablet Market Overview The Rugged Tablet Market is experiencing steady growth as industries seek durable and reliable computing devices for harsh environments. Rugged tablets are designed to withstand extreme temperatures, shocks, vibrations, dust, and water, making them ideal for sectors such as manufacturing, logistics, field services, defense, and healthcare. The
Canned Tuna Market Is Gaining Strength In 2026: Quality, Health & Regional Growth with 5.33 % CAGR By - 2035
Canned Tuna Market Is Gaining Strength In 2026: Quality, Health & Regional Growt …
Canned Tuna Market continues to demonstrate resilient growth as consumers increasingly seek convenient, nutritious, and shelf-stable protein sources. In 2026, the market is shaped by evolving dietary preferences, supply chain innovations, sustainability concerns, and dynamic regional consumption patterns. Once a basic pantry staple, canned tuna is now diversifying into premium and health-oriented segments that are driving fresh demand. Canned Tuna industry is projected to grow from 23.85 in 2025 to 39.82
Smart Home Device Market Size to Reach USD 185.34 Billion by 2035 Driven by Connected Living Trends
Smart Home Device Market Size to Reach USD 185.34 Billion by 2035 Driven by Conn …
The Smart Home Device Market report delivers comprehensive insights into market size, growth drivers, technology trends, competitive landscape, and regional outlook shaping the global industry. Smart Home Device Market Overview The Smart Home Device Market is experiencing strong growth as consumers increasingly adopt connected technologies to enhance comfort, security, energy efficiency, and convenience in residential environments. Smart home devices integrate IoT, artificial intelligence, voice assistants, and wireless connectivity to automate and remotely
Global Neuroendoscopy Market to Surpass USD 1297.9 Billion by 2035 as AI-Guided Navigation and Minimally Invasive Techniques Redefine Neurosurgery
Global Neuroendoscopy Market to Surpass USD 1297.9 Billion by 2035 as AI-Guided …
The global Neuroendoscopy Market is entering a high-growth phase, fueled by a surge in brain tumor cases and the rapid integration of robotics and artificial intelligence into surgical workflows. According to the latest 2026 industry intelligence, the market is valued at approximately USD 444.04 million and is projected to reach USD 1,297.90 million by 2035, expanding at a robust compound annual growth rate (CAGR) of 11.39%. Neuroendoscopy has emerged as a

All 5 Releases


More Releases for Pulmonary

Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum i …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025,
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments